Tuberculosis
Study Data from J.D. Selengut et al Provide New Insights into Tuberculosis
Published in Drug Week, September 9th, 2011
2011 SEP 9 -- Research findings, "Unexpected abundance of coenzyme F(420)-dependent enzymes in Mycobacterium tuberculosis and other actinobacteria," are discussed in a new report. According to the authors of recent research published in the Journal of Bacteriology, "Regimens targeting Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), require long courses of treatment and a combination of three or more drugs. An increase in drug-resistant strains of M. tuberculosis demonstrates the need for additional TB-specific drugs."
"A notable feature of M. tuberculosis is coenzyme F(420), which is distributed sporadically...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-09-09)
More Articles from Drug Week
- Research and Markets
Combination Devices - Application Landscape - Drug Abuse
Data on Drug Abuse Described by Researchers at University of Aarhus - Phenylpropionates
Investigators at University of Salamanca Publish New Data on Phenylpropionates - Antiprotozoal Agents
New Antiprotozoal Agents Findings from Council for Scientific and Industrial Research Published - Cancer Therapy
New Cancer Therapy Data Have Been Reported by Researchers at China Pharmaceutical University - Catecholamines
New Catecholamines Study Findings Have Been Reported from Institute of Pharmacology - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
